Evolving therapies for lower-risk myelodysplastic syndromes
Targeting TP53 Mutations in Myelodysplastic Syndromes
Coronavirus: What People with Cancer Should Know
Coronavirus: What People with Cancer Should Know
ON THIS PAGE
What is coronavirus, or COVID-19?
If I have cancer, am I at higher risk of getting or dying from COVID-19?
If I have cancer, how can I protect myself?
I receive cancer treatment at a medical facility. What should I do about getting treatment?
Against all odds: Unrelated stem cell transplants in coronavirus times
The COVID-19 crisis has consequences not only for those who have become infected and the doctors and nurses who care for them. The care of other patients is also threatened by the increasing stress that national health systems and societies as a whole are under.
Expanded Choices Emerge for Myelofibrosis Following Ruxolitinib Therapy
Ruben Mesa, MD
Newly approved and investigational agents are joining ruxolitinib (Jakafi) for the treatment of myelofibrosis (MF) and may provide options for patients who progress or become intolerant to frontline JAK inhibitors.
At the 24th Annual International Congress on Hematologic Malignancies, hosted by Physicians’ Education Resource®, LLC, Ruben Mesa, MD, who is director of the UT San Antonio MD Anderson Cancer Center, presented available and emerging therapy options for patients who require additional MF therapy following ruxolitinib.
(continued)
Coronavirus 2019: What People With Cancer Need to Know
Coronavirus 2019: What People With Cancer Need to Know
Merry Jennifer Markham, MD, FACP
March 25, 2020 · Merry Jennifer Markham, MD, FACP
This post is reviewed and updated every day. It was first published on March 3.
Frequently Asked Questions: Coronavirus Disease 2019 (COVID-19) and Maintaining Mental Health
The outbreak of coronavirus disease 2019 (COVID-19) may be stressful for people and communities. Fear and anxiety about a disease can be overwhelming and cause strong emotions in adults and children. Information follows about how to cope with mental health and stress and anxiety during this time:
(Links follow)
Stuck Inside? Come Hang Out With The Mighty Community!
Join The Mighty’s staff and community for a series of events designed to put the SOCIAL in social distancing. We’ve got writing workshops, fun events for kids, interactive Facebook Lives, and more!
Check out the schedule (con't)
MDS to AML, treatment and options with Dr. Tiffany Tanaka, UC San Diego
Dr. Tiffany Tanaka from the University of California, San Diego explains the development of High-Risk MDS into AML. She talks about new diagnostic and treatment regimens for these patients.